186 related articles for article (PubMed ID: 12081720)
1. De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia.
Kleefstra T; Yntema HG; Oudakker AR; Romein T; Sistermans E; Nillessen W; van Bokhoven H; de Vries BB; Hamel BC
Clin Genet; 2002 May; 61(5):359-62. PubMed ID: 12081720
[TBL] [Abstract][Full Text] [Related]
2. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics.
Kleefstra T; Yntema HG; Nillesen WM; Oudakker AR; Mullaart RA; Geerdink N; van Bokhoven H; de Vries BB; Sistermans EA; Hamel BC
Eur J Hum Genet; 2004 Jan; 12(1):24-8. PubMed ID: 14560307
[TBL] [Abstract][Full Text] [Related]
3. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
[TBL] [Abstract][Full Text] [Related]
4. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome.
Hammer S; Dorrani N; Dragich J; Kudo S; Schanen C
Ment Retard Dev Disabil Res Rev; 2002; 8(2):94-8. PubMed ID: 12112734
[TBL] [Abstract][Full Text] [Related]
5. Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion.
Oexle K; Thamm-Mücke B; Mayer T; Tinschert S
Eur J Pediatr; 2005 Mar; 164(3):154-7. PubMed ID: 15558314
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2).
Moog U; Smeets EE; van Roozendaal KE; Schoenmakers S; Herbergs J; Schoonbrood-Lenssen AM; Schrander-Stumpel CT
Eur J Paediatr Neurol; 2003; 7(1):5-12. PubMed ID: 12615169
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 mutations in children with and without the phenotype of Rett syndrome.
Hoffbuhr K; Devaney JM; LaFleur B; Sirianni N; Scacheri C; Giron J; Schuette J; Innis J; Marino M; Philippart M; Narayanan V; Umansky R; Kronn D; Hoffman EP; Naidu S
Neurology; 2001 Jun; 56(11):1486-95. PubMed ID: 11402105
[TBL] [Abstract][Full Text] [Related]
8. MECP2 mutations account for most cases of typical forms of Rett syndrome.
Bienvenu T; Carrié A; de Roux N; Vinet MC; Jonveaux P; Couvert P; Villard L; Arzimanoglou A; Beldjord C; Fontes M; Tardieu M; Chelly J
Hum Mol Genet; 2000 May; 9(9):1377-84. PubMed ID: 10814719
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of MECP2 mutations in Rett syndrome.
Lee SS; Wan M; Francke U
Brain Dev; 2001 Dec; 23 Suppl 1():S138-43. PubMed ID: 11738860
[TBL] [Abstract][Full Text] [Related]
10. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
11. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome.
Kim SJ; Cook EH
Hum Mutat; 2000 Apr; 15(4):382-3. PubMed ID: 10737989
[TBL] [Abstract][Full Text] [Related]
12. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype.
Weaving LS; Williamson SL; Bennetts B; Davis M; Ellaway CJ; Leonard H; Thong MK; Delatycki M; Thompson EM; Laing N; Christodoulou J
Am J Med Genet A; 2003 Apr; 118A(2):103-14. PubMed ID: 12655490
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis in Rett syndrome.
Milunsky JM; Lebo RV; Ikuta T; Maher TA; Haverty CE; Milunsky A
Genet Test; 2001; 5(4):321-5. PubMed ID: 11960578
[TBL] [Abstract][Full Text] [Related]
14. Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene.
Schwartzman JS; Bernardino A; Nishimura A; Gomes RR; Zatz M
Neuropediatrics; 2001 Jun; 32(3):162-4. PubMed ID: 11521215
[TBL] [Abstract][Full Text] [Related]
15. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients.
Huppke P; Laccone F; Krämer N; Engel W; Hanefeld F
Hum Mol Genet; 2000 May; 9(9):1369-75. PubMed ID: 10814718
[TBL] [Abstract][Full Text] [Related]
16. A case of Rett syndrome from Ukraine--clinical diagnosis confirmed by mutation analysis of the MECP2 gene.
Bzduch V; Zahorakova D; Grechanina E; Zdibskaja EP; Goldfarb IG; Zeman J; Martasek P
Bratisl Lek Listy; 2004; 105(9):299-302. PubMed ID: 15633890
[TBL] [Abstract][Full Text] [Related]
17. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
Buschdorf JP; Strätling WH
J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
[TBL] [Abstract][Full Text] [Related]
18. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
[TBL] [Abstract][Full Text] [Related]
19. Five novel frameshift mutations in exon 3 and 4 of the MECP2 gene identified in Rett patients: Consequences for the molecular diagnosis strategy.
Bienvenu T; Souville I; Poirier K; Aquaviva C; Burglen L; Amiel J; Héron B; Kaminska A; Couvert P; Beldjord C; Chelly J
Hum Mutat; 2001 Sep; 18(3):251-2. PubMed ID: 11524737
[TBL] [Abstract][Full Text] [Related]
20. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE; Zoghbi HY
Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
